205 related articles for article (PubMed ID: 9570649)
1. The lack of therapeutic effect of Saccharomyces boulardii in the prevention of antibiotic-related diarrhoea in elderly patients.
Lewis SJ; Potts LF; Barry RE
J Infect; 1998 Mar; 36(2):171-4. PubMed ID: 9570649
[TBL] [Abstract][Full Text] [Related]
2. Saccharomyces boulardii in the prevention of antibiotic-associated diarrhoea in children: a randomized double-blind placebo-controlled trial.
Kotowska M; Albrecht P; Szajewska H
Aliment Pharmacol Ther; 2005 Mar; 21(5):583-90. PubMed ID: 15740542
[TBL] [Abstract][Full Text] [Related]
3. Saccharomyces boulardii for the prevention of antibiotic-associated diarrhea in adult hospitalized patients: a single-center, randomized, double-blind, placebo-controlled trial.
Pozzoni P; Riva A; Bellatorre AG; Amigoni M; Redaelli E; Ronchetti A; Stefani M; Tironi R; Molteni EE; Conte D; Casazza G; Colli A
Am J Gastroenterol; 2012 Jun; 107(6):922-31. PubMed ID: 22472744
[TBL] [Abstract][Full Text] [Related]
4. Prophylactic Saccharomyces boulardii in the prevention of antibiotic-associated diarrhea: a prospective study.
Can M; Beşirbellioglu BA; Avci IY; Beker CM; Pahsa A
Med Sci Monit; 2006 Apr; 12(4):PI19-22. PubMed ID: 16572062
[TBL] [Abstract][Full Text] [Related]
5. Prevention and treatment of diarrhoea with Saccharomyces boulardii in children with acute lower respiratory tract infections.
Shan LS; Hou P; Wang ZJ; Liu FR; Chen N; Shu LH; Zhang H; Han XH; Han XX; Cai XX; Shang YX; Vandenplas Y
Benef Microbes; 2013 Dec; 4(4):329-334. PubMed ID: 24311316
[TBL] [Abstract][Full Text] [Related]
6. Meta-analysis: non-pathogenic yeast Saccharomyces boulardii in the prevention of antibiotic-associated diarrhoea.
Szajewska H; Mrukowicz J
Aliment Pharmacol Ther; 2005 Sep; 22(5):365-72. PubMed ID: 16128673
[TBL] [Abstract][Full Text] [Related]
7. Probiotics, antibiotic-associated diarrhoea and Clostridium difficile diarrhoea in humans.
Surawicz CM
Best Pract Res Clin Gastroenterol; 2003 Oct; 17(5):775-83. PubMed ID: 14507587
[TBL] [Abstract][Full Text] [Related]
8. Prevention of antibiotic-associated diarrhea by Saccharomyces boulardii: a prospective study.
Surawicz CM; Elmer GW; Speelman P; McFarland LV; Chinn J; van Belle G
Gastroenterology; 1989 Apr; 96(4):981-8. PubMed ID: 2494098
[TBL] [Abstract][Full Text] [Related]
9. Review article: yeast as probiotics -- Saccharomyces boulardii.
Czerucka D; Piche T; Rampal P
Aliment Pharmacol Ther; 2007 Sep; 26(6):767-78. PubMed ID: 17767461
[TBL] [Abstract][Full Text] [Related]
10. [A prospective control study of
Zhang DM; Xu BB; Yu L; Zheng LF; Chen LP; Wang W
Zhonghua Nei Ke Za Zhi; 2017 Jun; 56(6):398-401. PubMed ID: 28592037
[No Abstract] [Full Text] [Related]
11. Systematic review with meta-analysis: Saccharomyces boulardii in the prevention of antibiotic-associated diarrhoea.
Szajewska H; Kołodziej M
Aliment Pharmacol Ther; 2015 Oct; 42(7):793-801. PubMed ID: 26216624
[TBL] [Abstract][Full Text] [Related]
12. Efficacy and safety of Saccharomyces boulardii in prevention of antibiotic-associated diarrhoea due to Helicobacterpylori eradication.
Duman DG; Bor S; Ozütemiz O; Sahin T; Oğuz D; Iştan F; Vural T; Sandkci M; Işksal F; Simşek I; Soytürk M; Arslan S; Sivri B; Soykan I; Temizkan A; Beşşk F; Kaymakoğlu S; Kalayc C
Eur J Gastroenterol Hepatol; 2005 Dec; 17(12):1357-61. PubMed ID: 16292090
[TBL] [Abstract][Full Text] [Related]
13. Prevention of Clostridium difficile infection with Saccharomyces boulardii: a systematic review.
Tung JM; Dolovich LR; Lee CH
Can J Gastroenterol; 2009 Dec; 23(12):817-21. PubMed ID: 20011734
[TBL] [Abstract][Full Text] [Related]
14. [Efficacy of
Maev IV; Andreev DN; Sokolov PS; Fomenko AК; Devkota MK; Andreev NG; Zaborovsky AV
Ter Arkh; 2022 Nov; 94(10):1163-1170. PubMed ID: 36468990
[TBL] [Abstract][Full Text] [Related]
15. [A multicenter randomized controlled study of
Wan CM; Yu H; Liu G; Xu HM; Mao ZQ; Xu Y; Jin Y; Luo RP; Wang WJ; Fang F
Zhonghua Er Ke Za Zhi; 2017 May; 55(5):349-354. PubMed ID: 28482385
[No Abstract] [Full Text] [Related]
16. Comment on 'The lack of therapeutic effect of Saccharomyces boulardii in the prevention of antibiotic-related diarrhoea in elderly patients'.
Elmer GW; McFarland LV
J Infect; 1998 Nov; 37(3):307-8. PubMed ID: 9892543
[No Abstract] [Full Text] [Related]
17. Economic evaluation of S. boulardii CNCM I-745 for prevention of antibioticassociated diarrhoea in hospitalized patients.
Vermeersch SJ; Vandenplas Y; Tanghe A; Elseviers M; Annemans L
Acta Gastroenterol Belg; 2018; 81(2):269-276. PubMed ID: 30024698
[TBL] [Abstract][Full Text] [Related]
18. Saccharomyces boulardii for the prevention of hospital onset Clostridium difficile infection.
Flatley EA; Wilde AM; Nailor MD
J Gastrointestin Liver Dis; 2015 Mar; 24(1):21-4. PubMed ID: 25822430
[TBL] [Abstract][Full Text] [Related]
19. Treatment and prevention of antibiotic associated diarrhea.
Bergogne-Bérézin E
Int J Antimicrob Agents; 2000 Dec; 16(4):521-6. PubMed ID: 11118872
[TBL] [Abstract][Full Text] [Related]
20. Effects of Saccharomyces boulardii in children with acute diarrhoea.
Kurugöl Z; Koturoğlu G
Acta Paediatr; 2005 Jan; 94(1):44-7. PubMed ID: 15858959
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
